These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1310 related articles for article (PubMed ID: 15384015)

  • 1. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
    Iseki K; Kinjo K; Iseki C; Takishita S
    Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
    Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
    Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort.
    Iseki K; Tozawa M; Ikemiya Y; Kinjo K; Iseki C; Takishita S
    Clin Exp Nephrol; 2005 Mar; 9(1):46-52. PubMed ID: 15830273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.
    Chen JH; Chuang SY; Chen HJ; Yeh WT; Pan WH
    Arthritis Rheum; 2009 Feb; 61(2):225-32. PubMed ID: 19177541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of end-stage renal disease and body mass index in a screened cohort.
    Iseki K; Ikemiya Y; Fukiyama K
    Kidney Int Suppl; 1997 Dec; 63():S169-70. PubMed ID: 9407450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
    Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
    Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.
    Jafar TH; Schmid CH; Stark PC; Toto R; Remuzzi G; Ruggenenti P; Marcantoni C; Becker G; Shahinfar S; De Jong PE; De Zeeuw D; Kamper AL; Strangaard S; Levey AS
    Nephrol Dial Transplant; 2003 Oct; 18(10):2047-53. PubMed ID: 13679479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan.
    Iseki K; Iseki C; Ikemiya Y; Kinjo K; Takishita S
    Hypertens Res; 2007 Feb; 30(2):167-74. PubMed ID: 17460387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of uric acid with change in kidney function in healthy normotensive individuals.
    Bellomo G; Venanzi S; Verdura C; Saronio P; Esposito A; Timio M
    Am J Kidney Dis; 2010 Aug; 56(2):264-72. PubMed ID: 20385436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.
    Nan H; Qiao Q; Dong Y; Gao W; Tang B; Qian R; Tuomilehto J
    J Rheumatol; 2006 Jul; 33(7):1346-50. PubMed ID: 16821269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure and risk of end-stage renal disease in a screened cohort.
    Iseki K; Ikemiya Y; Fukiyama K
    Kidney Int Suppl; 1996 Jun; 55():S69-71. PubMed ID: 8743514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia.
    Lin KC; Tsao HM; Chen CH; Chou P
    J Rheumatol; 2004 Jun; 31(6):1152-8. PubMed ID: 15170929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperuricemia and the metabolic syndrome in Hangzhou.
    Cai Z; Xu X; Wu X; Zhou C; Li D
    Asia Pac J Clin Nutr; 2009; 18(1):81-7. PubMed ID: 19329400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
    Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
    Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
    Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
    Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial.
    Baker JF; Schumacher HR; Krishnan E
    Angiology; 2007; 58(4):450-7. PubMed ID: 17875958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.